Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06262347 · ClinicalTrials.gov registry record · NA

Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnant and Postpartum Persons in MOUD

A NA study, sponsored by T. John Winhusen, PhD.

Completed
Registry status
NA
Development phase
131
Enrollment target

NCT06262347 is a NA study that has completed, run by T. John Winhusen, PhD. The registered enrollment target is 131 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06262347, a NA study, has completed, sponsored by T. John Winhusen, PhD.

COMPLETED
Registry status
NA
Development phase
131 participants
Enrollment target

Study Summary

The primary objective of this study is to evaluate the ability of TOME to increase Medication for Opioid Use Disorder (MOUD) and opioid-overdose knowledge in pregnant and postpartum persons.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Personally-Tailored Opioid-overdose and Medication for opioid use disorder (MOUD) Education (TOME)

Trial Details

FieldValue
Enrollment Target 131 participants
Start Date 2024-06-13
Est. Completion 2024-11-11
Phase NA

Sponsor

T. John Winhusen, PhD

5 total trials

What the Registry Record Tells You About NCT06262347

The ClinicalTrials.gov registry entry for NCT06262347 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is T. John Winhusen, PhD, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT06262347 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06262347 about?

NCT06262347 is a clinical study titled "Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnant and Postpartum Persons in MOUD". The primary objective of this study is to evaluate the ability of TOME to increase Medication for Opioid Use Disorder (MOUD) and opioid-overdose knowledge in pregnant and postpartum persons.

What is the current status of trial NCT06262347?

This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2024-06-13. Estimated completion is 2024-11-11.

What interventions are being tested in trial NCT06262347?

The interventions under investigation include: Control (BEHAVIORAL), Personally-Tailored Opioid-overdose and Medication for opioid use disorder (MOUD) Education (TOME) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06262347?

This trial is sponsored by T. John Winhusen, PhD, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.